Bid to fund blood test tool for liver fibrosis
A blood test for liver fibrosis could help GPs risk-stratify the growing number of patients with non-alcoholic fatty liver disease, a conference has heard.
The Medical Services Advisory Committee (MSAC) is deciding whether to fund Hepascore, a four-biomarker blood test and prognostic tool developed in Perth, for all patients with chronic liver disease.
The test results, combined with age and gender, provide a score indicating the likelihood of fibrosis, with different cut-offs for different stages.
Co-developer Associate Professor Leon Adams, from the University of WA and Sir Charles